Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ryanodine Receptor Calcium Release Channel | 15 | 2025 | 241 | 3.290 |
Why?
|
| Muscle, Skeletal | 17 | 2025 | 1000 | 3.150 |
Why?
|
| Calcium | 15 | 2025 | 1028 | 2.470 |
Why?
|
| Malignant Hyperthermia | 9 | 2025 | 18 | 2.230 |
Why?
|
| Tacrolimus Binding Protein 1A | 5 | 2024 | 20 | 1.530 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2024 | 198 | 1.480 |
Why?
|
| Sarcoplasmic Reticulum | 7 | 2025 | 148 | 1.410 |
Why?
|
| Heat Stroke | 2 | 2025 | 6 | 1.220 |
Why?
|
| Calcium Channels, L-Type | 5 | 2025 | 52 | 0.950 |
Why?
|
| Calcium Signaling | 6 | 2025 | 246 | 0.910 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 126 | 0.770 |
Why?
|
| Muscular Diseases | 2 | 2021 | 124 | 0.730 |
Why?
|
| Mutation | 5 | 2021 | 6119 | 0.720 |
Why?
|
| Calcium-Binding Proteins | 4 | 2022 | 324 | 0.700 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 39 | 0.660 |
Why?
|
| Thermogenesis | 1 | 2020 | 56 | 0.640 |
Why?
|
| Heat Stress Disorders | 2 | 2022 | 10 | 0.550 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 591 | 0.530 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 38 | 0.530 |
Why?
|
| Animals | 28 | 2025 | 33862 | 0.510 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 54 | 0.500 |
Why?
|
| Muscle Proteins | 4 | 2025 | 404 | 0.490 |
Why?
|
| Mice | 20 | 2025 | 18243 | 0.480 |
Why?
|
| Software | 1 | 2020 | 735 | 0.460 |
Why?
|
| CD36 Antigens | 1 | 2015 | 35 | 0.460 |
Why?
|
| Sirolimus | 2 | 2014 | 229 | 0.430 |
Why?
|
| Calmodulin | 3 | 2010 | 210 | 0.430 |
Why?
|
| Calsequestrin | 4 | 2021 | 12 | 0.410 |
Why?
|
| Hot Temperature | 2 | 2012 | 141 | 0.410 |
Why?
|
| Ligands | 1 | 2014 | 486 | 0.380 |
Why?
|
| Fatty Acids | 1 | 2015 | 374 | 0.380 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 18 | 0.360 |
Why?
|
| Death, Sudden | 2 | 2012 | 45 | 0.360 |
Why?
|
| Ribonucleotides | 1 | 2012 | 31 | 0.350 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 170 | 0.320 |
Why?
|
| Oxidative Stress | 3 | 2024 | 796 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 4715 | 0.270 |
Why?
|
| Mice, Mutant Strains | 4 | 2017 | 358 | 0.240 |
Why?
|
| Muscle Contraction | 4 | 2022 | 146 | 0.240 |
Why?
|
| Peptides | 1 | 2009 | 705 | 0.230 |
Why?
|
| Excitation Contraction Coupling | 1 | 2025 | 14 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 521 | 0.230 |
Why?
|
| Point Mutation | 2 | 2025 | 334 | 0.230 |
Why?
|
| Serine | 1 | 2025 | 161 | 0.220 |
Why?
|
| Myocardium | 2 | 2024 | 863 | 0.210 |
Why?
|
| Phosphorylation | 3 | 2025 | 1579 | 0.200 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2015 | 139 | 0.200 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 66 | 0.200 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 191 | 0.190 |
Why?
|
| Muscle Weakness | 1 | 2023 | 90 | 0.190 |
Why?
|
| Models, Molecular | 3 | 2010 | 1060 | 0.180 |
Why?
|
| Exons | 1 | 2023 | 765 | 0.170 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 2336 | 0.170 |
Why?
|
| Mice, Inbred mdx | 1 | 2020 | 47 | 0.170 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 33 | 0.160 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 34 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 585 | 0.160 |
Why?
|
| Lactates | 1 | 2020 | 81 | 0.160 |
Why?
|
| Reactive Nitrogen Species | 2 | 2012 | 8 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 45 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 88 | 0.160 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 70 | 0.160 |
Why?
|
| Protein Binding | 3 | 2014 | 1660 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 661 | 0.140 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 192 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3834 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2020 | 565 | 0.140 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 46 | 0.140 |
Why?
|
| Muscle Strength | 2 | 2008 | 82 | 0.140 |
Why?
|
| Mitochondria | 2 | 2017 | 775 | 0.130 |
Why?
|
| Male | 10 | 2021 | 64488 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 434 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2022 | 101 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 1 | 2015 | 169 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 430 | 0.100 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 176 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 196 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 578 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1610 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2015 | 312 | 0.100 |
Why?
|
| Hypothermia | 1 | 2013 | 60 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 716 | 0.090 |
Why?
|
| Phenotype | 3 | 2020 | 4479 | 0.090 |
Why?
|
| Isometric Contraction | 2 | 2008 | 22 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1002 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 572 | 0.090 |
Why?
|
| Crystallography, X-Ray | 2 | 2009 | 364 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2017 | 4679 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 266 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 539 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 800 | 0.080 |
Why?
|
| Apoptosis | 1 | 2017 | 1832 | 0.080 |
Why?
|
| Caffeine | 3 | 2022 | 66 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 159 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 85 | 0.080 |
Why?
|
| Humans | 11 | 2025 | 130483 | 0.070 |
Why?
|
| Raptors | 1 | 2008 | 4 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 301 | 0.070 |
Why?
|
| Nitrosation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Rhabdomyolysis | 1 | 2008 | 35 | 0.070 |
Why?
|
| Long-Term Potentiation | 1 | 2008 | 106 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 24 | 0.070 |
Why?
|
| Mammals | 1 | 2009 | 253 | 0.070 |
Why?
|
| Superoxides | 1 | 2008 | 125 | 0.070 |
Why?
|
| Protein Conformation | 1 | 2009 | 731 | 0.070 |
Why?
|
| Fear | 1 | 2008 | 192 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 137 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4671 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 552 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3404 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2008 | 317 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 68 | 0.060 |
Why?
|
| Cryoelectron Microscopy | 1 | 2008 | 242 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2025 | 1597 | 0.060 |
Why?
|
| Young Adult | 1 | 2020 | 10010 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 185 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 787 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2406 | 0.060 |
Why?
|
| Action Potentials | 1 | 2008 | 470 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 13234 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3487 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2020 | 14945 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2009 | 929 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 118 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 665 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2022 | 36 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17550 | 0.050 |
Why?
|
| Adolescent | 1 | 2020 | 20737 | 0.040 |
Why?
|
| Neurons | 2 | 2008 | 2012 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2007 | 1343 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 28438 | 0.040 |
Why?
|
| Child | 1 | 2020 | 26101 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 31179 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 419 | 0.040 |
Why?
|
| Female | 4 | 2020 | 70388 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 223 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2008 | 237 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 938 | 0.030 |
Why?
|
| Anesthetics | 1 | 2018 | 77 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 808 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 805 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 562 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 34 | 0.030 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2015 | 37 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 51 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 715 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1487 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 56 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 138 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 279 | 0.020 |
Why?
|
| Torque | 1 | 2008 | 8 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 51 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 98 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 249 | 0.020 |
Why?
|
| Ryanodine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2008 | 39 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 235 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 292 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 102 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 250 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 130 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 412 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 202 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 236 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 62 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 243 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 314 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 324 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 488 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 419 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 987 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 469 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1386 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2345 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6200 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 1349 | 0.010 |
Why?
|